NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 258 filers reported holding NEOGENOMICS INC in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $174 | -12.6% | 12,601 | 0.0% | 0.00% | – |
| Q1 2024 | $199 | -40.2% | 12,601 | -38.8% | 0.00% | -100.0% |
| Q4 2023 | $333 | +44.2% | 20,601 | +9.3% | 0.00% | 0.0% |
| Q3 2023 | $231 | -10.5% | 18,851 | +17.8% | 0.00% | 0.0% |
| Q2 2023 | $258 | -6.9% | 16,006 | +0.7% | 0.00% | 0.0% |
| Q1 2023 | $277 | +274.3% | 15,901 | +98.8% | 0.00% | – |
| Q4 2022 | $74 | -99.9% | 8,000 | 0.0% | 0.00% | – |
| Q3 2022 | $69,000 | +6800.0% | 8,000 | +7820.8% | 0.00% | – |
| Q1 2022 | $1,000 | -85.7% | 101 | -47.7% | 0.00% | – |
| Q4 2021 | $7,000 | +40.0% | 193 | +91.1% | 0.00% | – |
| Q3 2021 | $5,000 | 0.0% | 101 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | 0.0% | 101 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | -64.3% | 101 | -61.2% | 0.00% | – |
| Q4 2020 | $14,000 | – | 260 | – | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2018 | $78,000 | – | 6,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 2,683,090 | $11,188,000 | 6.34% |
| GROW Partners, LLC | 1,140,300 | $4,755,000 | 4.35% |
| KOPP INVESTMENT ADVISORS LLC | 1,592,832 | $6,642,000 | 3.19% |
| PERKINS CAPITAL MANAGEMENT INC | 816,680 | $3,406,000 | 2.92% |
| 1492 Capital Management LLC | 786,495 | $3,280,000 | 2.05% |
| Curi RMB Capital, LLC | 4,177,053 | $17,418,000 | 1.06% |
| BARD ASSOCIATES INC | 491,100 | $2,048,000 | 0.96% |
| FALCON POINT CAPITAL, LLC | 162,475 | $678,000 | 0.62% |
| THB ASSET MANAGEMENT | 2,214,203 | $9,233,000 | 0.61% |
| NORTHPOINTE CAPITAL LLC | 1,033,821 | $4,311,000 | 0.52% |